South & Central America Influenza Vaccines Market Forecast to 2028 – COVID-19 Impact and Regional Analysis ­– by Vaccine Type (Quadrivalent Vaccines and Trivalent Vaccines), Virus Type (Influenza Virus Type A and Influenza Virus Type B), Technology (Egg-b

South & Central America Influenza Vaccines Market Forecast to 2028 – COVID-19 Impact and Regional Analysis ­– by Vaccine Type (Quadrivalent Vaccines and Trivalent Vaccines), Virus Type (Influenza Virus Type A and Influenza Virus Type B), Technology (Egg-based and Cell-based), Route of Administration (Injection and Nasal Spray), and Target Group (Infants, Children, Adults, and Elderly People)

The South & Central America influenza vaccines market is expected to grow from US$ 497.54 million in 2022 to US$ 736.35 million by 2028; it is estimated to grow at a CAGR of 6.8% from 2022 to 2028.

Increase in Government Support to Promote Influenza Vaccination

The governing bodies of various states and countries are supporting the promotion of vaccination through multiple activities and programs. By 2022, enough vaccines have been secured to cover all risk groups eligible for a government-funded flu vaccine through the NIP.

Below are a few more instances supporting the government support for influenza vaccination: In Oct 2021, with flu season approaching, the Provincial Government was encouraging all Newfoundlanders and Labradorians to get a flu shot in the year 2021. Starting October 25, 2021, the Regional Health Authorities (RHAs) have begun hosting free flu vaccination clinics. People can also get the vaccine through their family doctor or local pharmacy. Thus, increasing government support to promote influenza vaccination is driving the South & Central America influenza vaccines market.

Market Overview

The South & Central America influenza vaccines market is segmented into Brazil, Argentina, and the Rest of South & Central America. The market for influenza vaccines in the region is expected to experience growth opportunities during the forecast period. The influenza vaccines market in SAM is expected to grow owing to factors such as an increase in cases of influenza in the region, surge in various research activities in the region, rise in health awareness, and an increase in healthcare expenditure by the countries of the region.

South & Central America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Influenza Vaccines Market Segmentation

The South & Central America influenza vaccines market is segmented on the basis of vaccine type, virus type, technology, route of administration, target group, and country.

Based on vaccine type, the South & Central America influenza vaccines market is bifurcated into quadrivalent vaccines and trivalent vaccines. The quadrivalent vaccines segment registered a larger share of the market in 2022.

Based on virus type, the South & Central America influenza vaccines market is bifurcated into influenza virus type A and influenza virus type B. The influenza virus type A segment held a larger share of the market in 2022.

Based on technology, the South & Central America influenza vaccines market is divided into egg-based and cell-based. The egg-based segment held a larger share of the market in 2022.

Based on route of administration, the South & Central America influenza vaccines market is divided into injection and nasal spray. The injection segment held a larger share of the market in 2022.

Based on target group, the South & Central America influenza vaccines market is segmented into infants, children, adults, and elderly people. The infants segment held the largest share of the market in 2022.

Based on country, the South & Central America influenza vaccines market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the market in 2022.

AstraZeneca; GlaxoSmithKline plc.; Mitsubishi Chemical Group Corporation; MYLAN N.V.; Sanofi; SEQIRUS; and Serum Institute of India Pvt. Ltd are the leading companies operating in the South & Central America influenza vaccines market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America influenza vaccines market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in South & Central America influenza vaccines market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution